已收盘 07-02 16:00:00 美东时间
-0.010
-0.96%
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5.25美元升至5.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9美元升至9.25美元
06-09 11:33
Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price target from $9.5 to $10.
06-08 18:02
Myomo (AMEX:MYO) affirms FY2026 sales outlook from $43.000 million-$46.000 million to $43.000 million-$46.000 million vs $48.591 million estimate.
05-08 04:13
Gainers Zevra Therapeutics (NASDAQ:ZVRA) stock moved upwards by 20.6% to $11.0...
03-10 05:05
Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has
03-10 04:16
Myomo (AMEX:MYO) announced its Q4 earnings on Monday, March 9, 2026 at 04:06 PM...
03-10 04:08
Myomo (AMEX:MYO) sees FY2026 sales of $43.000 million-$46.000 million vs $48.591 million analyst estimate.
03-10 04:08
Myomo (AMEX:MYO) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 104.55 percent. This is a 800 percent decrease over losses of $(0.01) per share from the same
03-10 04:07
Companies Reporting Before The Bell • ZIM Integrated Shipping (NYSE:ZIM) is exp...
03-09 19:11
One of the great advantages individual investors have is time. We do not need t...
01-09 01:55